NEW DELHI: Drug giant Ranbaxy has ceased production of its generic version of cholesterol-busting drug Lipitor until it probes the issue of “possible” glass particles in some lots, a statement said yesterday.
The problem is the latest to beset the generics heavyweight, India’s largest drug firm by sales, which reached a deal with US regulators earlier this year over a lengthy quality compliance dispute in which it promised tighter checks. Ranbaxy on November 9 informed its customers of a “voluntary recall” of some lots of its atorvastatin tablets — the generic version of Lipitor, the US Food and Drug Administration (USFDA) said in statement on its website. The lots of atorvastatin, packaged in bottles of 90 and 500 tablets, are being recalled “due to possible contamination with very small glass particles similar to the size of a grain of sand”, the statement added. AFP